Symbols / EQ Stock $2.08 +1.46% Equillium, Inc.
EQ (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Ratings
Current target
$2.08
Low
$1.00
High
$12.00
Mean
$6.38
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-17 | reit | Roth Capital | Buy → Buy | $12 |
| 2026-04-16 | init | B. Riley Securities | — → Buy | $6 |
| 2026-04-14 | init | Raymond James | — → Strong Buy | $6 |
| 2026-03-13 | init | Roth Capital | — → Buy | $12 |
| 2025-03-28 | down | Leerink Partners | Outperform → Market Perform | $1 |
| 2024-11-01 | down | Jones Trading | Buy → Hold | — |
| 2024-08-19 | reit | HC Wainwright & Co. | Buy → Buy | $5 |
| 2024-06-05 | reit | HC Wainwright & Co. | Buy → Buy | $5 |
| 2024-05-17 | reit | HC Wainwright & Co. | Buy → Buy | $5 |
| 2024-04-02 | main | HC Wainwright & Co. | Buy → Buy | $5 |
| 2023-12-26 | main | HC Wainwright & Co. | Buy → Buy | $4 |
| 2023-11-13 | main | HC Wainwright & Co. | Buy → Buy | $5 |
| 2023-08-14 | reit | Cantor Fitzgerald | Overweight → Overweight | $3 |
| 2023-08-14 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2023-05-15 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2023-05-01 | main | HC Wainwright & Co. | — → Buy | $6 |
| 2023-03-24 | main | Stifel | — → Buy | $7 |
| 2023-02-08 | main | SVB Leerink | — → Outperform | $7 |
| 2022-09-27 | main | HC Wainwright & Co. | — → Buy | $20 |
| 2022-09-08 | main | SVB Leerink | — → Outperform | $12 |
News
RSS: Latest EQ news- $EQ stock is up 23% today. Here's what we see in our data. - Quiver Quantitative Wed, 10 Dec 2025 08
- Favourable Signals For EQ Resources: Numerous Insiders Acquired Stock - Yahoo Finance Sat, 04 Apr 2026 07
- Equillium management heads to Oppenheimer investor event - Stock Titan Mon, 20 Apr 2026 07
- Equillium (EQ) Receives Buy Rating from Roth Capital | EQ Stock News - GuruFocus Fri, 13 Mar 2026 07
- Should I buy Equillium (EQ) - Zacks Investment Research hu, 20 Nov 2025 08
- Top-Performing Stock ETFs - Morningstar Fri, 03 Apr 2026 07
- Is It Stable or Volatile | Equillium Inc. Posts 35.3% EPS Beat, Narrower Net Loss Vs Estimates - Stock Idea Sharing Hub - Cổng thông tin điện tử tỉnh Tây Ninh hu, 23 Apr 2026 04
- Here’s What Roth Capital Thinks of Equillium (EQ) Stock - Yahoo Finance ue, 24 Mar 2026 07
- Why EQ Resources Shares Are Quietly Climbing Higher - TipRanks Mon, 06 Apr 2026 07
- EQ and Raymond James Partner to Offer Clients a Comprehensive Equity Stock Plan Solution - GlobeNewswire Wed, 15 Oct 2025 07
- Experimental colitis pill gets $35M boost, funded into 2029 - Stock Titan Fri, 13 Mar 2026 07
- The Best Equity ETFs - Morningstar Mon, 02 Mar 2026 08
- New Equillium hire gets options for 32,000 shares at $2.04 - Stock Titan hu, 02 Apr 2026 07
- Insider Sale: Sr. Vice President and COO of $EQ Sells 11,900 Shares | EQ Stock News - Quiver Quantitative Mon, 15 Dec 2025 08
- Best US Stock ETFs for Canadian Investors - Morningstar Canada Fri, 23 Jan 2026 08
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
-100.00%
|
41.09
+13.89%
|
36.08
+128.97%
|
15.76
|
| Operating Revenue |
|
0.00
-100.00%
|
41.09
+13.89%
|
36.08
+128.97%
|
15.76
|
| Operating Expense |
|
23.63
-52.12%
|
49.36
-2.45%
|
50.61
-7.63%
|
54.79
|
| Research And Development |
|
12.84
-65.69%
|
37.43
+1.05%
|
37.04
-1.35%
|
37.55
|
| Selling General And Administration |
|
10.79
-9.59%
|
11.94
-12.02%
|
13.57
-21.30%
|
17.24
|
| General And Administrative Expense |
|
10.79
-9.59%
|
11.94
-12.02%
|
13.57
-21.30%
|
17.24
|
| Other Gand A |
|
10.79
-9.59%
|
11.94
-12.02%
|
13.57
-21.30%
|
17.24
|
| Total Expenses |
|
23.63
-52.12%
|
49.36
-2.45%
|
50.61
-7.63%
|
54.79
|
| Operating Income |
|
-23.63
-185.81%
|
-8.27
+43.06%
|
-14.52
+62.79%
|
-39.03
|
| Total Operating Income As Reported |
|
-23.63
-185.81%
|
-8.27
+43.06%
|
-14.52
+76.61%
|
-62.08
|
| EBITDA |
|
-23.52
-189.20%
|
-8.13
+33.00%
|
-12.14
+80.19%
|
-61.26
|
| Normalized EBITDA |
|
-23.52
-189.20%
|
-8.13
+33.00%
|
-12.14
+68.23%
|
-38.21
|
| Reconciled Depreciation |
|
0.12
-15.33%
|
0.14
+8.73%
|
0.13
+6.78%
|
0.12
|
| EBIT |
|
-23.63
-185.81%
|
-8.27
+32.58%
|
-12.26
+80.02%
|
-61.38
|
| Total Unusual Items |
|
—
|
—
|
0.00
+100.00%
|
-23.05
|
| Total Unusual Items Excluding Goodwill |
|
—
|
—
|
0.00
+100.00%
|
-23.05
|
| Special Income Charges |
|
—
|
—
|
0.00
+100.00%
|
-23.05
|
| Other Special Charges |
|
—
|
—
|
—
|
23.05
|
| Net Income |
|
-22.40
-177.65%
|
-8.07
+39.51%
|
-13.34
+78.64%
|
-62.43
|
| Pretax Income |
|
-22.40
-190.66%
|
-7.71
+39.58%
|
-12.76
+79.57%
|
-62.43
|
| Net Non Operating Interest Income Expense |
|
0.83
-39.68%
|
1.38
-25.07%
|
1.84
+391.15%
|
-0.63
|
| Interest Expense Non Operating |
|
—
|
0.00
-100.00%
|
0.49
-53.37%
|
1.05
|
| Net Interest Income |
|
0.83
-39.68%
|
1.38
-25.07%
|
1.84
+391.15%
|
-0.63
|
| Interest Expense |
|
—
|
0.00
-100.00%
|
0.49
-53.37%
|
1.05
|
| Interest Income Non Operating |
|
0.83
-39.68%
|
1.38
-40.83%
|
2.33
+455.71%
|
0.42
|
| Interest Income |
|
0.83
-39.68%
|
1.38
-40.83%
|
2.33
+455.71%
|
0.42
|
| Other Income Expense |
|
0.40
+149.27%
|
-0.82
-976.32%
|
-0.08
+99.67%
|
-22.77
|
| Other Non Operating Income Expenses |
|
0.40
+149.27%
|
-0.82
-976.32%
|
-0.08
-127.05%
|
0.28
|
| Tax Provision |
|
0.00
-100.00%
|
0.36
-37.76%
|
0.58
|
0.00
|
| Tax Rate For Calcs |
|
0.00
-100.00%
|
0.00
+0.00%
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-22.40
-177.65%
|
-8.07
+39.51%
|
-13.34
+78.64%
|
-62.43
|
| Net Income From Continuing Operation Net Minority Interest |
|
-22.40
-177.65%
|
-8.07
+39.51%
|
-13.34
+78.64%
|
-62.43
|
| Net Income From Continuing And Discontinued Operation |
|
-22.40
-177.65%
|
-8.07
+39.51%
|
-13.34
+78.64%
|
-62.43
|
| Net Income Continuous Operations |
|
-22.40
-177.65%
|
-8.07
+39.51%
|
-13.34
+78.64%
|
-62.43
|
| Normalized Income |
|
-22.40
-177.65%
|
-8.07
+39.51%
|
-13.34
+66.14%
|
-39.38
|
| Net Income Common Stockholders |
|
-22.40
-177.65%
|
-8.07
+39.51%
|
-13.34
+78.64%
|
-62.43
|
| Diluted EPS |
|
-0.39
-69.57%
|
-0.23
+39.47%
|
-0.38
+79.46%
|
-1.85
|
| Basic EPS |
|
-0.39
-69.57%
|
-0.23
+39.47%
|
-0.38
+79.46%
|
-1.85
|
| Basic Average Shares |
|
57.30
+62.07%
|
35.36
+1.82%
|
34.73
+2.96%
|
33.73
|
| Diluted Average Shares |
|
57.30
+62.07%
|
35.36
+1.82%
|
34.73
+2.96%
|
33.73
|
| Diluted NI Availto Com Stockholders |
|
-22.40
-177.65%
|
-8.07
+39.51%
|
-13.34
+78.64%
|
-62.43
|
| Line Item | Trend | 2023-12-31 |
|---|---|---|
| Total Assets |
|
50.53
|
| Current Assets |
|
49.35
|
| Cash Cash Equivalents And Short Term Investments |
|
40.87
|
| Cash And Cash Equivalents |
|
23.22
|
| Other Short Term Investments |
|
17.65
|
| Receivables |
|
6.29
|
| Accounts Receivable |
|
3.73
|
| Other Receivables |
|
0.50
|
| Taxes Receivable |
|
2.05
|
| Prepaid Assets |
|
1.96
|
| Other Current Assets |
|
0.23
|
| Total Non Current Assets |
|
1.18
|
| Net PPE |
|
1.11
|
| Gross PPE |
|
1.48
|
| Accumulated Depreciation |
|
-0.36
|
| Properties |
|
0.00
|
| Machinery Furniture Equipment |
|
0.66
|
| Other Properties |
|
0.80
|
| Leases |
|
0.02
|
| Other Non Current Assets |
|
0.07
|
| Total Liabilities Net Minority Interest |
|
27.96
|
| Current Liabilities |
|
27.57
|
| Payables And Accrued Expenses |
|
11.40
|
| Payables |
|
4.71
|
| Accounts Payable |
|
4.71
|
| Current Accrued Expenses |
|
6.70
|
| Total Tax Payable |
|
0.00
|
| Income Tax Payable |
|
0.00
|
| Current Debt And Capital Lease Obligation |
|
0.44
|
| Current Debt |
|
—
|
| Other Current Borrowings |
|
—
|
| Current Capital Lease Obligation |
|
0.44
|
| Current Deferred Liabilities |
|
15.73
|
| Current Deferred Revenue |
|
15.73
|
| Total Non Current Liabilities Net Minority Interest |
|
0.38
|
| Long Term Debt And Capital Lease Obligation |
|
0.38
|
| Long Term Debt |
|
—
|
| Long Term Capital Lease Obligation |
|
0.38
|
| Non Current Deferred Liabilities |
|
0.00
|
| Non Current Deferred Revenue |
|
0.00
|
| Stockholders Equity |
|
22.57
|
| Common Stock Equity |
|
22.57
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Share Issued |
|
35.25
|
| Ordinary Shares Number |
|
35.25
|
| Treasury Shares Number |
|
0.00
|
| Additional Paid In Capital |
|
208.17
|
| Retained Earnings |
|
-185.74
|
| Gains Losses Not Affecting Retained Earnings |
|
0.14
|
| Other Equity Adjustments |
|
0.14
|
| Total Equity Gross Minority Interest |
|
22.57
|
| Total Capitalization |
|
22.57
|
| Working Capital |
|
21.78
|
| Invested Capital |
|
22.57
|
| Total Debt |
|
0.82
|
| Capital Lease Obligations |
|
0.82
|
| Net Tangible Assets |
|
22.57
|
| Tangible Book Value |
|
22.57
|
| Interest Payable |
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-22.75
-19.55%
|
-19.03
+12.66%
|
-21.78
-149.43%
|
-8.73
|
| Cash Flow From Continuing Operating Activities |
|
-22.75
-19.55%
|
-19.03
+12.66%
|
-21.78
-149.43%
|
-8.73
|
| Net Income From Continuing Operations |
|
-22.40
-177.65%
|
-8.07
+39.51%
|
-13.34
+78.64%
|
-62.43
|
| Depreciation Amortization Depletion |
|
0.12
-15.33%
|
0.14
+8.73%
|
0.13
+6.78%
|
0.12
|
| Depreciation |
|
0.12
-15.33%
|
0.14
+8.73%
|
0.13
+6.78%
|
0.12
|
| Depreciation And Amortization |
|
0.12
-15.33%
|
0.14
+8.73%
|
0.13
+6.78%
|
0.12
|
| Other Non Cash Items |
|
—
|
-15.73
-71.53%
|
-9.17
-118.97%
|
48.33
|
| Stock Based Compensation |
|
2.32
-38.08%
|
3.75
-6.18%
|
4.00
-17.43%
|
4.84
|
| Operating Gains Losses |
|
-0.46
-157.30%
|
0.79
+1268.97%
|
0.06
-77.69%
|
0.26
|
| Net Foreign Currency Exchange Gain Loss |
|
-0.47
-159.70%
|
0.79
+1268.97%
|
0.06
-77.69%
|
0.26
|
| Gain Loss On Sale Of PPE |
|
0.02
|
0.00
|
—
|
—
|
| Change In Working Capital |
|
-2.32
-375.18%
|
0.84
+133.07%
|
-2.55
-13500.00%
|
0.02
|
| Change In Receivables |
|
0.00
-100.00%
|
3.73
+516.39%
|
-0.90
+68.39%
|
-2.84
|
| Changes In Account Receivables |
|
0.00
-100.00%
|
3.73
+516.39%
|
-0.90
+68.39%
|
-2.84
|
| Change In Prepaid Assets |
|
1.26
-44.48%
|
2.27
+226.04%
|
-1.80
-1042.41%
|
-0.16
|
| Change In Payables And Accrued Expense |
|
-3.62
+29.79%
|
-5.16
-3152.66%
|
0.17
-94.25%
|
2.94
|
| Change In Accrued Expense |
|
-1.69
+46.74%
|
-3.16
-471.12%
|
-0.55
-228.24%
|
0.43
|
| Change In Payable |
|
-1.94
+2.91%
|
-2.00
-375.93%
|
0.72
-71.17%
|
2.51
|
| Change In Account Payable |
|
-1.94
+2.91%
|
-2.00
-375.93%
|
0.72
-71.17%
|
2.51
|
| Change In Other Working Capital |
|
0.04
+566.67%
|
-0.01
+30.77%
|
-0.01
-117.33%
|
0.07
|
| Change In Other Current Assets |
|
—
|
—
|
—
|
—
|
| Change In Other Current Liabilities |
|
—
|
—
|
—
|
—
|
| Investing Cash Flow |
|
4.46
-67.68%
|
13.81
+390.09%
|
-4.76
-125.49%
|
18.68
|
| Cash Flow From Continuing Investing Activities |
|
4.46
-67.68%
|
13.81
+390.09%
|
-4.76
-125.49%
|
18.68
|
| Net PPE Purchase And Sale |
|
-0.04
+57.65%
|
-0.09
-70.00%
|
-0.05
+82.08%
|
-0.28
|
| Purchase Of PPE |
|
-0.05
+43.53%
|
-0.09
-70.00%
|
-0.05
+82.08%
|
-0.28
|
| Sale Of PPE |
|
0.01
|
0.00
|
—
|
—
|
| Capital Expenditure |
|
-0.05
+43.53%
|
-0.09
-70.00%
|
-0.05
+82.08%
|
-0.28
|
| Net Investment Purchase And Sale |
|
4.50
-67.62%
|
13.90
+394.97%
|
-4.71
-125.80%
|
18.26
|
| Purchase Of Investment |
|
0.00
+100.00%
|
-17.60
+67.83%
|
-54.71
-265.67%
|
-14.96
|
| Sale Of Investment |
|
4.50
-85.71%
|
31.50
-37.00%
|
50.00
+50.49%
|
33.23
|
| Net Business Purchase And Sale |
|
—
|
—
|
0.00
-100.00%
|
0.70
|
| Financing Cash Flow |
|
30.43
+18453.05%
|
0.16
+101.78%
|
-9.23
-659.51%
|
-1.22
|
| Cash Flow From Continuing Financing Activities |
|
30.43
+18453.05%
|
0.16
+101.78%
|
-9.23
-659.51%
|
-1.22
|
| Net Issuance Payments Of Debt |
|
—
|
0.00
+100.00%
|
-9.13
-539.12%
|
-1.43
|
| Repayment Of Debt |
|
—
|
0.00
+100.00%
|
-9.13
-539.12%
|
-1.43
|
| Long Term Debt Payments |
|
—
|
0.00
+100.00%
|
-9.13
-539.12%
|
-1.43
|
| Net Long Term Debt Issuance |
|
—
|
0.00
+100.00%
|
-9.13
-539.12%
|
-1.43
|
| Net Common Stock Issuance |
|
0.68
|
0.00
+100.00%
|
-0.26
|
0.00
|
| Common Stock Payments |
|
—
|
0.00
+100.00%
|
-0.26
|
0.00
|
| Repurchase Of Capital Stock |
|
—
|
0.00
+100.00%
|
-0.26
|
0.00
|
| Proceeds From Stock Option Exercised |
|
29.75
+18037.20%
|
0.16
-0.61%
|
0.17
-22.90%
|
0.21
|
| Changes In Cash |
|
12.14
+340.59%
|
-5.05
+85.89%
|
-35.77
-509.49%
|
8.74
|
| Effect Of Exchange Rate Changes |
|
0.05
+156.63%
|
-0.08
+29.66%
|
-0.12
-2460.00%
|
0.01
|
| Beginning Cash Position |
|
18.09
-22.10%
|
23.22
-60.72%
|
59.11
+17.35%
|
50.37
|
| End Cash Position |
|
30.28
+67.41%
|
18.09
-22.10%
|
23.22
-60.72%
|
59.11
|
| Free Cash Flow |
|
-22.79
-19.27%
|
-19.11
+12.47%
|
-21.83
-142.27%
|
-9.01
|
| Interest Paid Supplemental Data |
|
—
|
0.00
-100.00%
|
0.95
+11.69%
|
0.85
|
| Income Tax Paid Supplemental Data |
|
—
|
0.00
-100.00%
|
0.58
|
0.00
|
| Amortization Of Securities |
|
-0.01
+98.14%
|
-0.75
+17.51%
|
-0.91
-819.69%
|
0.13
|
| Common Stock Issuance |
|
0.68
|
0.00
|
—
|
0.00
|
| Issuance Of Capital Stock |
|
0.68
|
0.00
|
—
|
0.00
|
| Sale Of Business |
|
—
|
—
|
0.00
-100.00%
|
0.70
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 10-K2026-03-25 View
- 8-K2026-03-25 View
- 42026-03-16 View
- 8-K2026-03-13 View
- 42026-03-11 View
- 42026-02-23 View
- 42026-01-09 View
- 42026-01-09 View
- 42026-01-09 View
- 42026-01-09 View
- 42025-12-23 View
- 42025-12-15 View
- 42025-11-25 View
- 10-Q2025-11-13 View
- 8-K2025-11-13 View
- 8-K2025-10-06 View
- 8-K2025-09-19 View
- 8-K2025-09-04 View
- 42025-09-03 View
- 42025-09-03 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|